Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...
Legend Biotech Corporation looks like a J&J acquisition target as Carvykti sales surge and Phase 2 data impress. Click for ...
StockStory.org on MSN
Q4 earnings highlights: Regeneron (NASDAQ:REGN) vs the rest of the biotechnology stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
TheFly reported on April 22 that The Goldman Sachs Group raised its rating on GMAB from Neutral to Buy and set a price target ...
A prospective cohort study found that flossing may lower the risk for stroke, partly through a reduced incidence of atrial fibrillation.
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug ...
Congressional lawmakers introduced a raft of proposals this week, including bills to balance the power needs of data centers ...
13h
ADMA Biologics, Inc. (ADMA) Initiated at Buy as Canaccord Cites Improving Revenue and Margin Trends
TheFly reported on April 21 that Canaccord Genuity initiated coverage of ADMA with a Buy rating and set a price target of $21 ...
Measles is spreading in the shadows and could the HPV vaccine be beneficial to men too? Here are your top health stories for ...
Last weekend, President Donald Trump signed an executive order aimed at accelerating the review of psychedelic therapies for ...
Deals: Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, including $3.25 billion ...
Dr. William A. Haseltine is a distinguished scientist, philanthropist, author, and entrepreneur renowned for his pioneering work in genomics and regenerative medicine. A former Harvard Medical School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results